(Q44211775)

30 November 2017

Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population (English)

1 reference

30 November 2017

2

1 reference

30 November 2017

5

1 reference

30 November 2017

Almasi S

1

1 reference

PubMed ID

16775619

30 November 2017

Mojtahedi Z

series ordinal

3

1 reference

PubMed ID

16775619

30 November 2017

Rajaee A

series ordinal

4

1 reference

30 November 2017

15 June 2006

1 reference

30 November 2017

1 reference

30 November 2017

7

1 reference

30 November 2017

5

1 reference

30 November 2017

401-406

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gene.6364313

30 November 2017

0 references

cites work

Immunopathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Serologic abnormalities in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Phenotypic analysis of skin infiltrates in comparison with peripheral blood lymphocytes, spleen cells and thymocytes in early avian scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

A molecular perspective of CTLA-4 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

7 January 2021

Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

7 January 2021

The complex genetics of scleroderma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

7 January 2021

Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6364313

7 January 2021

Identifiers

DOI

10.1038/SJ.GENE.6364313

1 reference

30 November 2017

1 reference

PubMed ID

16775619